Oncologist, Chief Physician, a member of Chinese Society of Clinical Oncology (CSCO) of the Chinese Anti-Cancer Association. He graduated from the Department of Clinical Medicine of the University of South China. He has engaged himself in the medical oncology for more than 30 years, specializing in the clinical diagnosis and treatment of malignant tumors. Having engaged in advance studies in well-known cancer hospitals in China for many times, Prof. Xiang Qide has rich clinical experience in the integrated treatment of malignant tumors. He is specialized in combination therapy including chemotherapy, targeted therapy, immunotherapy and other treatments for lung cancer, breast cancer, colorectal cancer, liver cancer, stomach cancer, esophageal cancer, lymphoma, head and neck cancer. Especially, he excels in diagnostic bronchoscopy, bronchoscopy-guided tumor resection, tumor ablation, stent implantation and other diagnosis and treatment technology. He has published more than ten academic papers in national and provincial professional academic journals.

*Surgery, in addition to the appropriate chemotherapy and radiotherapy, are effective in treating early cancer, but certain patients in late stage of cancer may not be tolerate surgery well as they can be relatively weak. A combination of carefully planned minimally invasive therapy, chemotherapy or radiotherapy can effectively reduce the side effects and discomfort of treatment and may help patient get better efficacy.